Return to Clinical Trials Search Results
Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure - Thrombolysis in Myocardial Infarction 68 ( DAPA ACT HF-TIMI 68)
PRIMARY OBJECTIVE
To assess the effect of in-hospital initiation of
dapagliflozin, as compared with placebo, on
the clinical outcomes of cardiovascular death
or worsening heart failure in patients who have been stabilized during
hospitalization for acute heart failure.
To evaluate the safety and tolerability of in-hospital
initiation of dapagliflozin in this
patient population.
PRIMARY OBJECTIVE
To assess the effect of in-hospital initiation of
dapagliflozin, as compared with placebo, on
the clinical outcomes of cardiovascular death
or worsening heart failure in patients who have been stabilized during
hospitalization for acute heart failure.
To evaluate the safety and tolerability of in-hospital
initiation of dapagliflozin in this
patient population.
Recruitment Status
Current Studies